Cardiovascular complications of chronic kidney disease

Medicine (United Kingdom)

Volumn 43, Issue 8, 2015, Pages 469-473

  Lees, Jennifer S ^a   Mark, Patrick B ^b   Jardine, Alan G ^b  

^a WESTERN INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cardiovascular disease; cholesterol; chronic kidney disease; diabetes; hypertension; ischaemic heart disease; left ventricular hypertrophy; statins

Indexed keywords

CHOLESTEROL; FIBROBLAST GROWTH FACTOR 23; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARATHYROID HORMONE;

ALBUMINURIA; ANEMIA; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CALCIUM HOMEOSTASIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL (TOPIC); DIALYSIS; DYSLIPIDEMIA; END STAGE RENAL DISEASE; EVIDENCE BASED PRACTICE; GRAFT RECIPIENT; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; KIDNEY GRAFT; MORTALITY; PHOSPHATE METABOLISM; POPULATION; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SUDDEN CARDIAC DEATH;

EID: 84938739523     PISSN: 13573039     EISSN: 13654357     Source Type: Journal    
DOI: 10.1016/j.mpmed.2015.05.009     Document Type: Review

References (15)

1. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
2. A.G. Jardine, R.S. Gaston, B.C. Fellstrom, and H. Holdaas Prevention of cardiovascular disease in adult recipients of kidney transplants Lancet 378 2011 1419 1427
3. C. Wanner, V. Krane, W. Marz, and et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 2005 238 248
4. B.C. Fellstrom, A.G. Jardine, R.E. Schmieder, and et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 2009 1395 1407
5. C. Baigent, M.J. Landray, C. Reith, and et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 2011 2181 2192
6. H. Holdaas, and A.G. Jardine BP targets in renal transplant recipients: too high or too low? J Am Soc Nephrol 25 2014 1371 1373
7. R.K. Patel, P.B. Mark, N. Johnston, and et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: a single center prospective observational study Am J Transpl 8 2008 1673 1683
8. R.K. Patel, S. Oliver, P.B. Mark, and et al. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging Clin J Am Soc Nephrol 4 2009 1477 1483
9. M. Wolf Update on fibroblast growth factor 23 in chronic kidney disease Kidney Int 83 2012 737 747
10. H. Holdaas, B. Fellstrom, A.G. Jardine, and et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial Lancet 361 2003 2024 2031
11. C. Wanner, and M. Tonelli Kidney disease: improving Global outcomes lipid guideline development work group members. KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient Kidney Int 85 2014 1303 1309
12. N.W. Levin, P. Kotanko, K.U. Eckardt, and et al. Blood pressure in chronic kidney disease stage 5D-report from a kidney disease: improving global outcomes controversies conference Kidney Int 77 2010 273 284
13. T.B. Drueke, F. Locatelli, N. Clyne, and et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia N Engl J Med 355 2006 2071 2084
14. The EVOLVE Trial Investigators Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis N Engl J Med 367 2012 2482 2494
15. F. Zannad, M. Kessler, P. Lehert, and et al. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies Kidney Int 70 2006 1318 1324